Farr Miller & Washington’s Globus Medical GMED Stock Holding History

Farr Miller & Washington’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.12M	Buy	27,674 +2,184	+9%	+$175K	0.14%	69
2021 Q2	$1.98M	Buy	25,490 +2,315	+10%	+$165K	0.13%	69
2021 Q1	$1.43M	Buy	23,175 +570	+3%	+$36.1K	0.1%	82
2020 Q4	$1.47M	Buy	22,605 +410	+2%	+$23.6K	0.11%	73
2020 Q3	$1.1M	Buy	22,195 +1,045	+5%	+$53.9K	0.1%	81
2020 Q2	$1.01M	Sell	21,150 -375	-2%	-$18.1K	0.08%	80
2020 Q1	$915K	Buy	21,525 +130	+0.6%	+$6.42K	0.09%	69
2019 Q4	$1.26M	Buy	21,395 +2,608	+14%	+$142K	0.09%	63
2019 Q3	$960K	Buy	18,787 +2,532	+16%	+$121K	0.08%	69
2019 Q2	$688K	Buy	16,255 +945	+6%	+$41K	0.06%	82
2019 Q1	$756K	Hold	15,310	–	–	0.06%	75
2018 Q4	$663K	Buy	15,310 +355	+2%	+$17.7K	0.06%	76
2018 Q3	$849K	Buy	14,955 +180	+1%	+$9.47K	0.07%	70
2018 Q2	$746K	Buy	14,775 +185	+1%	+$9.65K	0.07%	70
2018 Q1	$727K	Buy	14,590 +480	+3%	+$22.6K	0.07%	76
2017 Q4	$580K	Hold	14,110	–	–	0.05%	86
2017 Q3	$419K	Buy	+14,110	New	+$431K	0.04%	105

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Farr Miller & Washington's GMED Position: Q3 2021 in Review

Farr Miller & Washington increased its Globus Medical (GMED) stake by 8.6% in Q3 2021, buying an estimated $175K and bringing the position to 27,674 shares worth $2.12M. The position accounts for 0.14% of the portfolio, ranked #69.

Farr Miller & Washington first reported a position in GMED in Q3 2017 and has held it in 17 quarters since. 388 funds tracked by Wall St. Rank hold GMED as of Q3 2021.

Farr Miller & Washington held 27,674 shares of Globus Medical worth $2.12M as of Q3 2021.
Farr Miller & Washington bought 2,184 Globus Medical shares in Q3 2021, an estimated $175K.
Globus Medical made up 0.14% of Farr Miller & Washington's portfolio in Q3 2021, its #69 holding.
Farr Miller & Washington first reported a position in Globus Medical in Q3 2017 and has held it in 17 quarters since.
388 funds tracked by Wall St. Rank held Globus Medical as of Q3 2021.

Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.